We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
On the top, protein expression in current human tissue, based on all annotated cell types, is reported with the units not detected (n), low (l), medium (m) and high (h). Underneath, protein expression in each annotated cell type are reported using the same units.
Protein expression data is based on knowledge-based annotation. For genes where more than one antibody has been used, a collective score is set.
If knowledge-based annotation could not be performed for a gene, no data is displayed here. View antibody staining data further down this page.
A summary of mRNA expression data available for current tissue based on several datasets. The mRNA expression levels in human tissues are based on RNA-seq data generated by the Human Protein Atlas (HPA), Genotype-Tissue Expression (GTEx) portal and CAGE data generated by the FANTOM5 consortium. Consensus normalized expression (NX) levels for human tissues was created by combining the data from these three transcriptomics datasets (HPA, GTEx and FANTOM5).
The mRNA expression levels in pig are based on RNA-seq data generated by the Human Protein Atlas (HPA), and for mouse, HPA data and in situ hybridization generated by the Allen brain atlas are reported.
Scroll down to view mRNA expression data in more detail.
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high. This score is based on the staining intensity and fraction of stained cells.
The RNA-seq details section shows detailed information about the individual samples used for the transcript profiling and results of the RNA-seq analysis.
Information about each individual sample is listed below, including gender, age, a tissue section image and estimated fractions of cell types. pTPM (transcripts per million) values give a quantification of the gene abundance which is comparable between different genes and samples.
Cells in tubules: 60 Cells in glomeruli: 20 Fibroblasts: 5 Other cell types: 15
Female, age 67
Kidney sample 56 pTPM: 115.8
Cell types%
Cells in tubules: 70 Cells in glomeruli: 15 Fibroblasts: 10 Other cell types: 5
Female, age 55
Kidney sample 57 pTPM: 89.2
Cell types%
Cells in tubules: 80 Cells in glomeruli: 10 Fibroblasts: 5 Other cell types: 5
Male, age 46
Kidney sample 58 pTPM: 109.7
Cell types%
Cells in tubules: 60 Cells in glomeruli: 25 Fibroblasts: 5 Other cell types: 10
Female, age 57
Kidney sample 358 pTPM: 106.8
Cell types%
Cells in tubules: 60 Cells in glomeruli: 10 Fibroblasts: 10 Other cell types: 20
Male, age 78
Kidney sample 377 pTPM: 149.1
Cell types%
Cells in tubules: 65 Cells in glomeruli: 10 Fibroblasts: 5 Other cell types: 20
Male, age 73
Kidney sample 380 pTPM: 160.4
Cell types%
Cells in tubules: 60 Cells in glomeruli: 10 Fibroblasts: 10 Other cell types: 20
Female, age 59
Kidney sample 394 pTPM: 167
Cell types%
Cells in tubules: 65 Cells in glomeruli: 10 Fibroblasts: 10 Other cell types: 15
Female, age 48
Kidney sample 414 pTPM: 194.8
Cell types%
Cells in tubules: 60 Cells in glomeruli: 5 Fibroblasts: 10 Other cell types: 25
KIDNEY - GTEx RNA-seqi
RNA-Seq data generated by the Genotype-Tissue Expression (GTEx) project from human tissues is reported as average pTPM. More information can be found on the GTEx portal.
Distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. pTPM values of the individual samples are presented next to the box plot.
Max pTPM: 154.1
Min pTPM: 12.7
Std pTPM: 22.1
Median pTPM: 30.7
GTEX-13NYB-1726-SM-5N9G2
40-49 years, male
154.1
GTEX-14E6D-2526-SM-5YYA9
50-59 years, male
77.0
GTEX-N7MS-1626-SM-3LK5F
60-69 years, male
67.7
GTEX-ZE9C-1426-SM-4WKGM
60-69 years, male
51.5
GTEX-1AX8Z-2326-SM-731CR
60-69 years, male
48.9
GTEX-11TTK-1926-SM-5PNW8
60-69 years, female
42.2
GTEX-ZYT6-2226-SM-5GIC9
30-39 years, male
40.6
GTEX-14C5O-2026-SM-5YYB1
60-69 years, male
39.6
GTEX-17F97-1926-SM-7IGM4
50-59 years, male
39.4
GTEX-145MN-0326-SM-5QGQI
30-39 years, male
39.2
GTEX-147F4-2626-SM-5Q5CS
50-59 years, male
38.9
GTEX-1497J-0826-SM-5NQAJ
60-69 years, male
36.8
GTEX-12696-0926-SM-5FQTV
60-69 years, male
35.7
GTEX-17HHY-2326-SM-7KFSR
50-59 years, male
34.6
GTEX-16MT8-1926-SM-7EPGL
60-69 years, female
34.2
GTEX-P4QS-1126-SM-3NMD5
60-69 years, male
34.0
GTEX-15CHQ-2126-SM-6871M
60-69 years, male
32.6
GTEX-ZYFG-1626-SM-5GZYY
60-69 years, female
32.4
GTEX-QLQW-1626-SM-4R1K1
30-39 years, male
31.5
GTEX-12WSG-0826-SM-5EQ5A
50-59 years, female
31.4
GTEX-13OVL-1826-SM-5KLZR
50-59 years, male
31.3
GTEX-13112-2126-SM-5GCO4
50-59 years, male
31.2
GTEX-1EKGG-2226-SM-7IGOA
60-69 years, male
30.7
GTEX-1BAJH-1826-SM-731DA
70-79 years, male
30.4
GTEX-ZLFU-0926-SM-5P9F8
40-49 years, male
28.5
GTEX-XPVG-0526-SM-4B65N
50-59 years, male
28.1
GTEX-11OF3-1326-SM-5N9FJ
60-69 years, male
28.0
GTEX-RN64-1626-SM-48FD7
50-59 years, male
26.2
GTEX-13RTJ-2226-SM-5S2Q1
60-69 years, male
25.8
GTEX-T5JC-1526-SM-4DM68
20-29 years, male
25.8
GTEX-Y5V6-2026-SM-5IFHO
60-69 years, male
25.7
GTEX-1A3MW-2226-SM-73KUX
60-69 years, female
24.6
GTEX-13OVI-1126-SM-5KLZF
60-69 years, female
23.0
GTEX-QDVN-1626-SM-48TZC
50-59 years, male
23.0
GTEX-11GS4-2326-SM-5A5KS
60-69 years, male
22.8
GTEX-13OW6-1826-SM-5N9F9
50-59 years, male
21.9
GTEX-ZVZP-0926-SM-5GIDB
50-59 years, male
20.1
GTEX-1C6VQ-2326-SM-7IGN1
50-59 years, male
19.2
GTEX-15DYW-2026-SM-6AJBD
60-69 years, female
17.7
GTEX-14C39-2126-SM-664OH
40-49 years, male
16.8
GTEX-1399S-0526-SM-5IJG8
30-39 years, female
16.5
GTEX-ZDXO-0226-SM-4WKH7
60-69 years, male
15.5
GTEX-ZC5H-1726-SM-5HL7X
40-49 years, female
15.3
GTEX-NPJ8-2226-SM-3TW8D
40-49 years, male
13.9
GTEX-13O1R-2526-SM-5N9FW
60-69 years, male
12.7
Show allShow less
KIDNEY - FANTOM5 CAGEi
RNA expression in human tissues obtained through Cap Analysis of Gene Expression (CAGE) generated by the FANTOM5 project are reported as Scaled Tags Per Million.